Hypoxia-induced MIR155 is a potent autophagy inducer by targeting multiple players in the MTOR pathway

Citations Over TimeTop 10% of 2013 papers

Abstract

Hypoxia activates autophagy, an evolutionarily conserved cellular catabolic process. Dysfunction in the autophagy pathway has been implicated in an increasing number of human diseases, including cancer. Hypoxia induces upregulation of a specific set of microRNAs (miRNAs) in a variety of cell types. Here, we describe hypoxia-induced MIR155 as a potent inducer of autophagy. Enforced expression of MIR155 increases autophagic activity in human nasopharyngeal cancer and cervical cancer cells. Knocking down endogenous MIR155 inhibits hypoxia-induced autophagy. We demonstrated that MIR155 targets multiple players in MTOR signaling, including RHEB, RICTOR, and RPS6KB2. MIR155 suppresses target-gene expression by directly interacting with their 3' untranslated regions (UTRs), mutations of the binding sites abolish their MIR155 responsiveness. Furthermore, by downregulating MTOR signaling, MIR155 also attenuates cell proliferation and induces G 1/S cell cycle arrest. Collectively, these data present a new role for MIR155 as a key regulator of autophagy via dysregulation of MTOR pathway.

Related Papers

• → A small molecule inhibitor of Rheb selectively targets mTORC1 signaling(2018)96 cited
• → Rheb and Rags come together at the lysosome to activate mTORC1(2013)96 cited
• → Mammalian Target of Rapamycin Complex I (mTORC1) Activity in Ras Homologue Enriched in Brain (Rheb)-Deficient Mouse Embryonic Fibroblasts(2013)16 cited
• → Abstract IA07: The TSC complex links PI3K to mTOR and cancer metabolism(2015)
• → Abstract IA02: The PI3K-mTOR signaling network and tumor cell metabolism(2020)